Kal Rao is a Consultant to the Healthcare team at Berkshire Partners. He is involved with current Berkshire portfolio company Precision for Medicine. Prior to joining Berkshire in 2022, Kal was an associate at KKR. He began his career at Morgan Stanley as an analyst. Kal received an M.B.A. from Harvard Business School and a B.S. from University of North Carolina Kenan-Flagler Business School.